US Stock MarketDetailed Quotes

Neumora Therapeutics (NMRA)

Watchlist
  • 1.780
  • -0.120-6.32%
Close May 13 16:00 ET
  • 1.880
  • +0.100+5.62%
Post 20:01 ET
329.81MMarket Cap-1.34P/E (TTM)

Neumora Therapeutics (NMRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.94%-46.4M
-12.85%-206.44M
4.74%-47.96M
-39.27%-46.63M
6.68%-52.4M
-38.40%-59.45M
-12.04%-182.94M
2.14%-50.34M
29.91%-33.48M
-81.03%-56.16M
Net income from continuing operations
21.38%-53.46M
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
Operating gains losses
---71K
--47K
----
----
----
----
----
----
----
----
Depreciation and amortization
-94.90%8K
-67.04%208K
-94.27%9K
-85.26%23K
-88.13%19K
-0.63%157K
-5.54%631K
-5.42%157K
-9.83%156K
-6.43%160K
Other non cash items
-45.61%477K
-5.43%3.13M
-13.20%743K
-63.70%310K
48.15%1.2M
10.87%877K
-95.08%3.31M
-98.68%856K
-0.58%854K
-4.47%812K
Change In working capital
-45.71%-765K
-101.93%-437K
336.65%3.21M
-84.77%4.48M
15.82%-7.6M
-114.62%-525K
354.37%22.64M
89.66%-1.36M
2,567.23%29.43M
-277.22%-9.03M
-Change in prepaid assets
70.19%1.64M
-117.42%-2.77M
-693.49%-3.56M
-101.84%-326K
101.49%145K
-86.86%966K
239.51%15.91M
107.37%599K
356.79%17.69M
-129.56%-9.74M
-Change in payables and accrued expense
-306.60%-2.34M
-57.80%4.27M
741.24%6.81M
-62.16%4.77M
-541.19%-6.74M
80.53%-576K
71.19%10.11M
73.92%-1.06M
91.93%12.6M
-84.97%1.53M
-Change in other current assets
----
---53K
--0
--1K
----
----
--0
--0
--0
----
-Change in other current liabilities
92.68%-67K
44.35%-1.88M
94.85%-46K
104.53%39K
-16.55%-958K
-14.09%-915K
0.73%-3.38M
2.19%-893K
0.92%-861K
-0.24%-822K
Cash from discontinued investing activities
Operating cash flow
21.94%-46.4M
-12.85%-206.44M
4.74%-47.96M
-39.27%-46.63M
6.68%-52.4M
-38.40%-59.45M
-12.04%-182.94M
2.14%-50.34M
29.91%-33.48M
-81.03%-56.16M
Investing cash flow
Cash flow from continuing investing activities
-99.84%71K
338.84%168.52M
143.16%42.65M
-67.31%51.32M
43.01%30.4M
129.44%44.16M
-209.58%-70.56M
-822.37%-98.8M
559.20%156.99M
-11.72%21.26M
Net PPE purchase and sale
--71K
--218K
--63K
--71K
--84K
--0
--0
--0
--0
--0
Net investment purchase and sale
--0
341.18%168.3M
143.10%42.58M
-67.36%51.25M
42.62%30.31M
129.59%44.16M
-201.00%-69.78M
-639.56%-98.8M
558.18%156.99M
-11.72%21.26M
Net other investing changes
----
----
----
----
----
----
83.12%-775K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-99.84%71K
338.84%168.52M
143.16%42.65M
-67.31%51.32M
43.01%30.4M
129.44%44.16M
-209.58%-70.56M
-822.37%-98.8M
559.20%156.99M
-11.72%21.26M
Financing cash flow
Cash flow from continuing financing activities
10.88M
256.84%77.09M
277.37%58.77M
-108.88%-136K
595.44%18.46M
0
-90.69%21.6M
3,337.63%15.57M
-99.34%1.53M
808.90%2.65M
Net issuance payments of debt
----
--57.16M
--38.9M
---136K
----
----
--0
--0
--0
----
Net common stock issuance
--10.88M
43.52%19.65M
41.20%19.65M
----
----
--0
-94.12%13.69M
2,934.83%13.92M
----
----
Net preferred stock issuance
----
----
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
----
-96.52%275K
-86.94%216K
--0
-97.78%59K
--0
176.93%7.91M
99.28%1.65M
16.21%1.76M
556.93%2.65M
Cash from discontinued financing activities
Financing cash flow
--10.88M
256.84%77.09M
277.37%58.77M
-108.88%-136K
595.44%18.46M
--0
-90.69%21.6M
3,337.63%15.57M
-99.34%1.53M
808.90%2.65M
Net cash flow
Beginning cash position
27.32%182.53M
-61.80%143.36M
-53.39%129.07M
-18.02%124.52M
-30.45%128.07M
-61.80%143.36M
54.93%375.25M
-33.03%276.93M
-26.06%151.89M
-13.18%184.14M
Current changes in cash
-131.93%-35.46M
116.89%39.17M
140.02%53.46M
-96.36%4.55M
88.99%-3.55M
92.00%-15.29M
-274.29%-231.89M
-249.23%-133.57M
-39.91%125.04M
-384.80%-32.25M
End cash Position
14.83%147.07M
27.32%182.53M
27.32%182.53M
-53.39%129.07M
-18.02%124.52M
-30.45%128.07M
-61.80%143.36M
-61.80%143.36M
-33.03%276.93M
-26.06%151.89M
Free cash flow
21.94%-46.4M
-12.85%-206.44M
4.77%-47.94M
-39.32%-46.65M
6.68%-52.4M
-38.40%-59.45M
-11.96%-182.94M
2.23%-50.34M
29.97%-33.48M
-81.03%-56.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.94%-46.4M-12.85%-206.44M4.74%-47.96M-39.27%-46.63M6.68%-52.4M-38.40%-59.45M-12.04%-182.94M2.14%-50.34M29.91%-33.48M-81.03%-56.16M
Net income from continuing operations 21.38%-53.46M2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M
Operating gains losses ---71K--47K--------------------------------
Depreciation and amortization -94.90%8K-67.04%208K-94.27%9K-85.26%23K-88.13%19K-0.63%157K-5.54%631K-5.42%157K-9.83%156K-6.43%160K
Other non cash items -45.61%477K-5.43%3.13M-13.20%743K-63.70%310K48.15%1.2M10.87%877K-95.08%3.31M-98.68%856K-0.58%854K-4.47%812K
Change In working capital -45.71%-765K-101.93%-437K336.65%3.21M-84.77%4.48M15.82%-7.6M-114.62%-525K354.37%22.64M89.66%-1.36M2,567.23%29.43M-277.22%-9.03M
-Change in prepaid assets 70.19%1.64M-117.42%-2.77M-693.49%-3.56M-101.84%-326K101.49%145K-86.86%966K239.51%15.91M107.37%599K356.79%17.69M-129.56%-9.74M
-Change in payables and accrued expense -306.60%-2.34M-57.80%4.27M741.24%6.81M-62.16%4.77M-541.19%-6.74M80.53%-576K71.19%10.11M73.92%-1.06M91.93%12.6M-84.97%1.53M
-Change in other current assets -------53K--0--1K----------0--0--0----
-Change in other current liabilities 92.68%-67K44.35%-1.88M94.85%-46K104.53%39K-16.55%-958K-14.09%-915K0.73%-3.38M2.19%-893K0.92%-861K-0.24%-822K
Cash from discontinued investing activities
Operating cash flow 21.94%-46.4M-12.85%-206.44M4.74%-47.96M-39.27%-46.63M6.68%-52.4M-38.40%-59.45M-12.04%-182.94M2.14%-50.34M29.91%-33.48M-81.03%-56.16M
Investing cash flow
Cash flow from continuing investing activities -99.84%71K338.84%168.52M143.16%42.65M-67.31%51.32M43.01%30.4M129.44%44.16M-209.58%-70.56M-822.37%-98.8M559.20%156.99M-11.72%21.26M
Net PPE purchase and sale --71K--218K--63K--71K--84K--0--0--0--0--0
Net investment purchase and sale --0341.18%168.3M143.10%42.58M-67.36%51.25M42.62%30.31M129.59%44.16M-201.00%-69.78M-639.56%-98.8M558.18%156.99M-11.72%21.26M
Net other investing changes ------------------------83.12%-775K--0--0--0
Cash from discontinued investing activities
Investing cash flow -99.84%71K338.84%168.52M143.16%42.65M-67.31%51.32M43.01%30.4M129.44%44.16M-209.58%-70.56M-822.37%-98.8M559.20%156.99M-11.72%21.26M
Financing cash flow
Cash flow from continuing financing activities 10.88M256.84%77.09M277.37%58.77M-108.88%-136K595.44%18.46M0-90.69%21.6M3,337.63%15.57M-99.34%1.53M808.90%2.65M
Net issuance payments of debt ------57.16M--38.9M---136K----------0--0--0----
Net common stock issuance --10.88M43.52%19.65M41.20%19.65M----------0-94.12%13.69M2,934.83%13.92M--------
Net preferred stock issuance --------------------------0------------
Proceeds from stock option exercised by employees -----96.52%275K-86.94%216K--0-97.78%59K--0176.93%7.91M99.28%1.65M16.21%1.76M556.93%2.65M
Cash from discontinued financing activities
Financing cash flow --10.88M256.84%77.09M277.37%58.77M-108.88%-136K595.44%18.46M--0-90.69%21.6M3,337.63%15.57M-99.34%1.53M808.90%2.65M
Net cash flow
Beginning cash position 27.32%182.53M-61.80%143.36M-53.39%129.07M-18.02%124.52M-30.45%128.07M-61.80%143.36M54.93%375.25M-33.03%276.93M-26.06%151.89M-13.18%184.14M
Current changes in cash -131.93%-35.46M116.89%39.17M140.02%53.46M-96.36%4.55M88.99%-3.55M92.00%-15.29M-274.29%-231.89M-249.23%-133.57M-39.91%125.04M-384.80%-32.25M
End cash Position 14.83%147.07M27.32%182.53M27.32%182.53M-53.39%129.07M-18.02%124.52M-30.45%128.07M-61.80%143.36M-61.80%143.36M-33.03%276.93M-26.06%151.89M
Free cash flow 21.94%-46.4M-12.85%-206.44M4.77%-47.94M-39.32%-46.65M6.68%-52.4M-38.40%-59.45M-11.96%-182.94M2.23%-50.34M29.97%-33.48M-81.03%-56.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More